Associations of serum short-chain fatty acids with circulating immune cells and serum biomarkers in patients with multiple sclerosis
Abstract Altered composition of gut bacteria and changes to the production of their bioactive metabolites, the short-chain fatty acids (SCFAs), have been implicated in the development of multiple sclerosis (MS). However, the immunomodulatory actions of SCFAs and intermediaries in their ability to in...
Main Authors: | Stephanie Trend, Jonatan Leffler, Anderson P. Jones, Lilian Cha, Shelley Gorman, David A. Brown, Samuel N. Breit, Allan G. Kermode, Martyn A. French, Natalie C. Ward, Prue H. Hart |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-84881-8 |
Similar Items
-
FcγRIIb Expression Is Decreased on Naive and Marginal Zone-Like B Cells From Females With Multiple Sclerosis
by: Stephanie Trend, et al.
Published: (2021-01-01) -
Narrowband UVB phototherapy reduces TNF production by B‐cell subsets stimulated via TLR7 from individuals with early multiple sclerosis
by: Stephanie Trend, et al.
Published: (2020-01-01) -
Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated Syndrome
by: Stephanie Trend, et al.
Published: (2018-07-01) -
Circulating angiostatin serum level in patients with systemic sclerosis
by: Zofia Gerlicz-Kowalczuk, et al.
Published: (2017-12-01) -
Serum Fatty Acids and Hyperactivity
by: J Gordon Millichap
Published: (1987-09-01)